Literature DB >> 16542878

Increased frequency of HLA-B44 in recurrent sinopulmonary infections (RESPI).

Douglas T Johnston1, Gregory Mehaffey, Judy Thomas, K Randall Young, Howard Wiener, Jian Li, Rodney C P Go, Harry W Schroeder.   

Abstract

To test whether MHC alleles associated with common variable immune deficiency (CVID) might also be over-represented in patients with normal serum immunoglobulin levels who suffer with recurrent sinopulmonary infections (RESPI), we identified 62 consecutive RESPI patients and compared their HLA-B and HLA-DR antigen frequencies to those of 60 consecutive patients with CVID, 1627 Alabama Caucasian bone marrow donors, and 997,230 published US Caucasians. Either HLA-B44, -B8, -DR3(17), or -DR7 was present in 74% of the RESPI and 85% of the CVID patients. HLA-B44 prevalence in particular proved identical between RESPI and CVID. When compared to US Caucasians, the increased prevalence of the four HLA alleles proved significant at P < 0.0001, P < 0.0001, P = 0.0005, and P = 0.02, respectively. When compared to Alabama Caucasians, only the increased prevalence of HLA-B44 achieved statistical significance (P = 0.0001). Inheritance of HLA-B44 may yield susceptibility to recurrent sinopulmonary infection even in the presence of normal serum immunoglobulin levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542878     DOI: 10.1016/j.clim.2006.02.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

2.  Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Authors:  M A Julie Westerink; Harry W Schroeder; Moon H Nahm
Journal:  Aging Dis       Date:  2011-07-20       Impact factor: 6.745

3.  Examining the use of ICD-9 diagnosis codes for primary immune deficiency diseases in New York State.

Authors:  Elena S Resnick; Priyanka Bhatt; Peter Sidi; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2012-09-01       Impact factor: 8.317

4.  Histocompatibility Complex Status and Mendelian Randomization Analysis in Unsolved Antibody Deficiency.

Authors:  Hassan Abolhassani; Che Kang Lim; Asghar Aghamohammadi; Lennart Hammarström
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

5.  HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy.

Authors:  Pierpaolo Correale; Luciano Mutti; Francesca Pentimalli; Giovanni Baglio; Rita Emilena Saladino; Pierpaolo Sileri; Antonio Giordano
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

6.  HLA major allele group frequencies in a diverse population of the Free State Province, South Africa.

Authors:  Walter J Janse van Rensburg; André de Kock; Chené Bester; Jean F Kloppers
Journal:  Heliyon       Date:  2021-04-21

7.  Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.

Authors:  Manda L Waldrep; Yingxin Zhuang; Harry W Schroeder
Journal:  BMC Med Genet       Date:  2009-09-23       Impact factor: 2.103

Review 8.  Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.

Authors:  Filippo Migliorini; Ernesto Torsiello; Filippo Spiezia; Francesco Oliva; Markus Tingart; Nicola Maffulli
Journal:  Eur J Med Res       Date:  2021-08-03       Impact factor: 2.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.